Create Account | Sign In: Author or Forum

Search Symptoms

CONFERENCE NEWS

ASCO: Pembrolizumab Is Good Second-Line Tx in Urothelial CA

February 21, 2017. 1:00 PM EST. Findings for patients with advanced urothelial CA that recurred or progressed after platinum-based chemo Read article

OTHER CONFERENCE NEWS

Chemo-Related Cardiotoxicity Worse in Diabetes Patients

December 19, 2016 Those with diabetes showed more early warning signs of heart failure

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

December 09, 2016 'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

December 09, 2016 Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

December 09, 2016 Women on aromatase inhibitors exhibit less elasticity in their blood vessels

SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects

December 09, 2016 Perceived side effects might lead some to stop taking the medication, researchers say

SABCS: Rx Combo Promising in Advanced HR+, HER2− Breast CA

December 09, 2016 Everolimus added to fulvestrant appears to improve progression-free survival

ASH: Single Dose of Gene Therapy Effective in Hemophilia B

December 08, 2016 Small, preliminary trial suggests it may free hemophilia B patients from transfusions

Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC

December 08, 2016 Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed

SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years

December 07, 2016 Study found women who continued with letrozole did experience other benefits, however

Cannabidiol May Help Treat Intractable Epilepsy

December 07, 2016 CBD lowers seizure frequency, severity in some patients with Dravet, Lennox-Gastaut syndromes

Drug Shows Promise in Clear Cell, Papillary Renal Cell Cancer

November 30, 2016 93 percent had tumor growth controlled for median of more than eight months, researchers report

Funding for Cancer Research Needs to Be a Global Priority

November 29, 2016 Conference organizers call for worldwide research partnerships

ASN: Multidisciplinary Care Cost-Effective in CKD

November 21, 2016 Multidisciplinary care costs $24,613 per quality-adjusted life-year gained compared to usual care

ASN: Smoking May Negate Some Benefits of Rx Therapy in CKD

November 18, 2016 Possibly because cigarette smoking causes oxidative stress

ASN: Acid Suppression Therapy Linked to Kidney Stones, CKD

November 18, 2016 Two studies show increased risk of kidney stones with PPI, H2 blocker use; CKD with PPI use